PRA Health Sciences Inc

PRA Health Sciences — Q4 2014 Earnings Presentation

13 slides from PRA Health Sciences's earnings presentation, Feb 18, 2015

  1. Slide 1: Q4 2014 Earnings

    Q4 2014 Earnings February 18, 2015

  2. Slide 2: Forward Looking Statements and Use of Non-GAAP Financial Measures

    Forward Looking Statements and Use of Non-GAAP Financial Measures This presentation contains forward-looking statements that reflect, among other things, the Company’s current expectations and anticipated results of operations, all of which are subject to known and unknown risks, uncertainties and o

  3. Slide 3: Q4 and FY 2014 Financial Results

    Q4 and FY 2014 Financial Results ($ in millions) Q4 2014 Q4 2013 % Change FY 2014 FY 2013 % Change Service Revenue 323.8 $ 298.8 $ 8.4% 1,266.6 $ 832.9 $ 52.1% EBITDA 17.4 $ 21.0 $ -17.1% 134.6 $ (20.7) $ -750.2% Adjusted EBITDA 50.6 $ 35.3 $ 43.3% 182.8 $ 130.6 $ 40.0% Adjusted EBITDA Margin 15.6%

  4. Slide 4: Trailing Quarterly Performance

    Trailing Quarterly Performance FY 14 v ($ in millions) FY 13 % Q1 Q2 Q3 Q4 FY Q1 Q2 Q3 Q4 FY Change Service revenue 166.5 $ 179.5 $ 188.1 $ 298.8 $ 832.9 $ 311.4 $ 311.3 $ 320.1 $ 323.8 $ 1,266.6 $ 52.1% % growth Y-o-Y 13.0% 22.2% 27.9% 91.7% 39.5% 87.0% 73.4% 70.2% 8.4% 52.1% % growth Y-o-Y (consta

  5. Slide 5: Backlog and New Business Awards

    Backlog and New Business Awards FY 14 v ($ in millions) FY 13 % Q1 Q2 Q3 Q4 FY Q1 Q2 Q3 Q4 FY Change Beginning Backlog 1,382.8 $ 1,421.2 $ 1,444.2 $ 1,465.6 $ 1,382.8 $ 1,939.7 $ 1,987.3 $ 2,044.8 $ 2,091.5 $ 1,939.7 $ Ending Backlog 1,421.2 $ 1,444.2 $ 1,465.6 $ 1,939.7 $ 1,939.7 $ 1,987.3 $ 2,044.

  6. Slide 6: Debt Structure

    Debt Structure Weighted Average ($ in millions) December 31, March 31, June 30, September 30, December 31, Interest Maturity 2013 2014 2014 2014 2014 Rate Date Senior debt: First Lien 887.8 $ 885.6 $ 883.3 $ 881.1 $ 729.0 $ 4.50% September 23, 2020 Senior Notes 375.0 375.0 375.0 375.0 225.0 9.50% Oc

  7. Slide 7: Reconciliation of GAAP EBITDA to Adjusted EBITDA

    Reconciliation of GAAP EBITDA to Adjusted EBITDA For further information regarding the reconciliation of non-GAAP measures to their corresponding GAAP equivalent please see our press release Twelve Twelve Months Months Ended Ended ($ in millions) December 31, December 31, 2014 2013 2014 2013 Net los

  8. Slide 8: Reconciliation of GAAP Net Loss to Adjusted Net Income

    Reconciliation of GAAP Net Loss to Adjusted Net Income For further information regarding the reconciliation of non-GAAP measures to their corresponding GAAP equivalent please see our press release Twelve Twelve Months Months Ended Ended ($ in millions, except per share datat) December 31, December 3

  9. Slide 9: Reconciliation of GAAP Income (Loss) from Operations to Adjusted Income from Operations

    Reconciliation of GAAP Income (Loss) from Operations to Adjusted Income from Operations For further information regarding the reconciliation of non-GAAP measures to their corresponding GAAP equivalent please see our press release Twelve Twelve Months Months Ended Ended ($ in millions) December 31, D

  10. Slide 10: Appendix

    Appendix RAHEALTHSCIEN.

  11. Slide 11: Geographic Breakdown

    Geographic Breakdown Region Q4 14 Q4 13 US/Canada $ 193.4 $ 175.0 Europe/Africa 102.9 100.5 Latin America 13.4 13.4 Asia/Pacific 14.1 9.9 Total Service Revenue $ 323.8 $ 298.8 Region FY 2014 FY 2013 US/Canada $ 755.5 $ 438.9 Europe/Africa 402.7 341.1 Latin America 54.0 26.5 Asia/Pacific 54.4 26.4 To

  12. Slide 12: Days Sales Outstanding

    Days Sales Outstanding ($ in millions) Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Accounts Receivable, net 136.9 $ 157.4 $ 141.2 $ 232.6 $ 246.0 $ 241.9 $ 236.1 $ 233.2 $ Unbilled Services 63.1 56.2 58.3 62.3 102.3 98.0 113.2 105.5 Total Accounts Receivable and Unbilled Services 200.0 213.6 199.5 294.9 348.3 339.9 349

  13. Slide 13: siz

    siz OS PRAHEALTHSCIENCES HEF URE OF CLINICAL DEVELOPMEN

PRA Health Sciences — Q4 2014 Earnings Presentation on 6ix